首页 | 本学科首页   官方微博 | 高级检索  
检索        

左旋咪唑与呋喃氟脲嘧啶伍用对小鼠抗肿瘤及免疫功能的影响
引用本文:张永恒,王艳.左旋咪唑与呋喃氟脲嘧啶伍用对小鼠抗肿瘤及免疫功能的影响[J].肿瘤,1993,13(3):143-145.
作者姓名:张永恒  王艳
作者单位:黑龙江省肿瘤医院药剂科 (张永恒,王艳),黑龙江省肿瘤医院药剂科(吴玉波)
摘    要:本文采用呋喃氟脲嘧啶(FT-207)与增效减毒剂左旋咪唑(LMS)伍用来提高FT-207的疗效。结果伍用对小鼠S-180肉瘤的抑制作用与LMS的剂量有关,以低剂量的LMS(1mg/kg)抑瘤最佳,并能拮抗FT-207所致小鼠白细胞下降,增加小鼠胸腺和脾脏重量,促进小鼠腹腔内巨噬细胞吞噬功能,提高小鼠脾脏中NK细胞活性。

关 键 词:左旋咪唑  呋喃氟脲嘧啶  抗肿瘤  小鼠

Effect of Ftorafur Combined Levamisli on Antineoplasm and Immue Function in Mice
Zhang Yongheng,Wan Yan,Wu Yubo Tumor Hospital of Heilongjiang Province,Harbin.Effect of Ftorafur Combined Levamisli on Antineoplasm and Immue Function in Mice[J].Tumor,1993,13(3):143-145.
Authors:Zhang Yongheng  Wan Yan  Wu Yubo Tumor Hospital of Heilongjiang Province  Harbin
Abstract:The article reports that Ftorafur (FT-207) combined Levamisli(LMS) can incr-iease the curative effect of FT-207. The results shows that FT-207 Combined LMS onnhibition function of S180 sarcoma in mice concerns with the dosage of LMS. Low-dose LMS (1mg/kg) can increase the number of white blood cells, the weight ofthymus and spleen, the phagocytosis of macrophage and the activity of spleen NKcells in mice.
Keywords:Ftorafur  Levamisli  Antineoplasm  Mice
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号